These findings were consistent with our recent findings that the early prediabetic but not the diabetic treatment on db/db mice with the combined Smad7 agonist Asiatic acid and Smad3 inhibitor Naringenin (AANG) can effectively prevent T2D and T2DN 37. This evidence concerns the gene SMAD3 and type 2 diabetes mellitus.